[1]
“The Relationship between Interleukin 6 (IL-6) Levels and Disease Activity (SLEDAI-2K) and Manifestations of Renal and Non-Renal Damage in Patients with Systemic Lupus Erythematosus: Research”, Cermin Dunia Kedokteran, vol. 53, no. 01, pp. 6–11, Jan. 2026, doi: 10.55175/cdk.v53i01.1596.